Zevra Therap Drug Patent Portfolio
Zevra Therap owns 1 orange book drug protected by 5 US patents Given below is the list of Zevra Therap's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8461137 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | 22 Feb, 2031 | Active |
| US8748413 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | 10 Jul, 2030 | Active |
| US8828978 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | 01 Jul, 2030 | Active |
| US9132125 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | 01 Jul, 2030 | Active |
| US9549923 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof | 01 Jul, 2030 | Active |
Latest Legal Activities on Zevra Therap's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Zevra Therap.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 23 Feb, 2023 | US9132125 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 02 Mar, 2022 | US8828978 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 06 Oct, 2021 | US8748413 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 12 Oct, 2020 | US8461137 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 21 May, 2020 | US9549923 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 22 Feb, 2019 | US9132125 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 22 Feb, 2018 | US8828978 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 08 Nov, 2017 | US8748413 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 24 Jan, 2017 | US9549923 |
|
Recordation of Patent Grant Mailed
Critical
| 24 Jan, 2017 | US9549923 |
|
Email Notification
Critical
| 05 Jan, 2017 | US9549923 |
|
Issue Notification Mailed
Critical
| 04 Jan, 2017 | US9549923 |
| Dispatch to FDC | 19 Dec, 2016 | US9549923 |
|
Application Is Considered Ready for Issue
Critical
| 17 Dec, 2016 | US9549923 |
|
Issue Fee Payment Verified
Critical
| 12 Dec, 2016 | US9549923 |
Zevra Therap's Family Patents
Zevra Therap drugs have patent protection in a total of 20 countries. It's US patent count contributes only to 39.5% of its total global patent coverage. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Zevra Therap Drug List
Given below is the complete list of Zevra Therap's drugs and the patents protecting them.
1. Apadaz
Apadaz is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8461137 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
22 Feb, 2031
(6 years from now)
| Active |
| US8748413 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
10 Jul, 2030
(5 years from now)
| Active |
| US8748413 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
01 Jul, 2030
(5 years from now)
| Active |
| US8828978 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
01 Jul, 2030
(5 years from now)
| Active |
| US9132125 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
01 Jul, 2030
(5 years from now)
| Active |
| US9549923 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof |
01 Jul, 2030
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Apadaz's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List